Neuralink's Journey and the Broadening Horizons of Brain-Computer Interface Technology
Neuralink, Elon Musk's brain-implant company, has just revealed that it received approval from the U.S. Food and Drug Administration (FDA) …
Latest Insights
Valo Therapeutics' Innovative Immuno-Oncology Therapy PeptiCRAd-1 Begins Human Trials
Valo Therapeutics Oy (ValoTx), a frontrunner in the development of advanced immunotherapies for cancer, has initiated its Phase I trial …
How Syntekabio’s Supercomputing Enables AI-driven Drug Discovery
What is "supercomputing"? It refers to processing a massive quantity of complex data-intensive and computation-heavy problems often found in scientific …
FDA Recognizes SiSaf's siRNA Therapy, SIS-101-ADO, for Autosomal Dominant Osteopetrosis Treatment
In a noteworthy development in the pharmaceutical industry, SiSaf Ltd, a renowned RNA delivery and therapeutics firm, recently announced that …
LabGenius Showcases AI-Driven Antibody Discovery Platform in a T-cell Engager Demonstration
London-based LabGenius, known for its innovative approach to antibody discovery, recently revealed impressive results from its research platform demonstration project. …
The Rising Influence of Machine Learning and Coding in Biotechnology (a Survey)
The landscape of biotechnology is rapidly evolving, with coding and machine learning becoming integral to the innovative processes. A recent …
Bruker Acquires ZONTAL, Boosting Digital Transformation in Pharma Laboratories
The pharmaceutical industry is undergoing a significant shift as digital transformation in pharma continues to reshape the landscape. Bruker Corporation, …
Advancing Cell-free Biocomputing
Researchers from the University of Minnesota have published a study in Nature Communications introducing a new biocomputing method, Transcriptional RNA …
From Qubits to Cures: The Promise of Quantum Computing in Pharmaceutical Research and Development (a Realistic View)
In a recent announcement, Moderna and IBM unveiled their partnership aimed at utilizing cutting-edge technologies, such as artificial intelligence (AI) …
The Power of STB CLOUD in Remote AI Drug Discovery
STB CLOUD is Syntekabio’s latest cloud-based, fully automated AI platform. It’s designed for developers to engage in their drug discovery …
AI Drug Discovery: Unleashing the Potential of Big Data and Machine Learning
The terms “big data”, “machine learning”, and “artificial intelligence” have been trending in the AI drug discovery space for several …
RetinAI and Boehringer Ingelheim Collaborate on AI-Driven Drug Discovery for Geographic Atrophy Treatment
Established in 2017 in Swiss, RetinAI Medical AG is a notable player in clinical and imaging data management software and …